GlyR α Antibodies

Santa Cruz Biotechnology offers a broad range of GlyR α monoclonal antibodies for research focused on glycine receptor signaling. GlyR α monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GlyR α, a subunit of the glycine receptor, plays a crucial role in mediating inhibitory neurotransmission in the central nervous system. Its proper functioning is essential for maintaining the balance between excitatory and inhibitory signals, which is vital for normal motor control and sensory processing. Dysregulation of GlyR α has been implicated in various neurological disorders, making it an important target for therapeutic research. Understanding GlyR α function and regulation can provide valuable insights into potential treatment strategies for neurological conditions. Investigating GlyR α expression patterns helps reveal its distribution across different neural tissues and cell types. Studying GlyR α interactions with other proteins enhances our knowledge of synaptic transmission mechanisms. Santa Cruz Biotechnology monoclonal antibodies for GlyR α support researchers worldwide in advancing neuroscience and contributing to potential therapeutic breakthroughs.